Blockchain Registration Transaction Record
Pacylex Pharmaceuticals Welcomes Industry Veteran Michael Kamdar to Board of Directors
Pacylex Pharmaceuticals appoints Michael Kamdar to Board of Directors, emphasizing commitment to advancing novel cancer therapies. Industry veteran Kamdar's expertise poised to accelerate development of hematologic and solid tumor treatments.

This news highlights the strategic addition of Michael Kamdar to Pacylex's leadership team, signaling a new phase of growth and development for the company's groundbreaking cancer therapies. Kamdar's vast experience and track record in the life science industry will likely drive Pacylex's innovative programs towards clinical success, potentially revolutionizing cancer treatment.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xc874770f395f4c32bf908397e763efd1d941affbdc6c58e4840225de4b0922ed |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | mildPtXh-e6f6108d4d19f7d4e7f177280b6b0e98 |